Regulatory Probe, Patent Lawsuit, and Deepening Losses: Can Breo倍轻松 Find Relief?

6 mins read
December 26, 2025

Breo倍轻松 (688793.SH), once hailed as China’s pioneering ‘portable massage device first stock,’ finds itself at a critical juncture. A sudden regulatory probe, a high-stakes patent lawsuit, and rapidly deteriorating financial performance have converged, casting a long shadow over the company’s future and testing investor confidence. This confluence of crises raises a pressing question for the market: can the brand that promised relaxation navigate its own turmoil and find a path back to sustainable growth?

Executive Summary: The Mounting Pressure on Breo倍轻松

– The China Securities Regulatory Commission (CSRC 中国证监会) has launched a formal investigation into Breo倍轻松 and its controlling shareholder, Ma Xuejun (马学军), for suspected information disclosure violations, sending the stock price plummeting.
– The probe follows a pattern of regulatory scrutiny, with the Shanghai Stock Exchange (上海证券交易所) issuing multiple inquiry letters related to annual reports and uncovering complex pathways of alleged fund diversion by the controlling shareholder.
– Concurrently, the company faces a 10 million yuan patent infringement lawsuit from Japan’s Daido Motor Industry Co., Ltd., adding legal uncertainty to its operational challenges.
– Financial performance has sharply reversed, with Q3 2025 revenue down 34% year-on-year and net profit plunging over 600%, signaling a profound struggle against intense competition and shifting consumer demand.
– The situation presents a critical test of corporate governance and strategic direction, forcing a reevaluation of Breo倍轻松’s investment thesis in China’s crowded consumer health electronics sector.

A Regulatory Storm Erupts: The CSRC Investigation

The calm for Breo倍轻松 was shattered on December 25th. The company disclosed that it, along with its actual controller and Chairman Ma Xuejun, had separately received Lian Gaozhishu (立案告知书) – formal notices of case filing – from the CSRC. The allegation: suspected violations of information disclosure laws and regulations.

The market’s reaction was swift and severe. By the close of trading on December 26th, Breo倍轻松’s stock price had crashed by 14.68%, a clear signal of eroded investor trust. While the company’s public statement emphasized normal operations and full cooperation with the investigation, the regulatory cloud now hangs heavy.

Not an Isolated Incident: A History of Scrutiny

This investigation did not materialize out of thin air. For Breo倍轻松, it represents an escalation of persistent regulatory attention. Between 2022 and 2025, the Shanghai Stock Exchange issued information disclosure inquiry letters concerning the company’s annual reports and interim reports. These inquiries appear to have been precursors, focusing regulatory spotlight on the company’s financial communications.

Public disclosures have shed light on the potential core issues. Reports indicate that Ma Xuejun and related parties allegedly diverted company funds through several intricate channels:
– Employee Loans: From 2021 to 2022, funds totaling 4.08 million yuan were reportedly diverted through loans to company employees.
– Related-Party Lending: In 2024, significant sums were channeled through an associate company, Shenzhen Xingjiashun Trading Co., Ltd. (深圳市星佳顺贸易有限公司), involving net transfers of 52 million yuan, later partially repaid.
– Supplier Pre-payments: Between 2023-2024, a mechanism where the company prepaid suppliers, who then forwarded funds to Ma Xuejun’s related parties, is alleged to have involved 30.55 million yuan.

These patterns suggest deep-seated governance concerns that the CSRC probe will now formally examine.

The Question of Timing: A Major Shareholder Reduction

Adding to the market’s unease is the timing of a significant transaction by the very individual under investigation. Just one month prior to the CSRC notice, in late November, Ma Xuejun executed a large block sale of 2.55 million shares, representing 2.97% of the company’s equity, via a inquiry transfer. The transaction, priced at 25.35 yuan per share, netted him approximately 64.71 million yuan, officially for “personal funding needs.”

This reduction pushed the combined stake held by Ma Xuejun and his concerted parties below the 50% threshold, to 49.38%. While not illegal, the proximity of a major insider sell-off to a regulatory bombshell inevitably fuels skepticism and questions about alignment between controlling shareholders and minority investors.

From Market Pioneer to Pressured Player: The Breo倍轻松 Story

To understand the gravity of the current crisis, one must appreciate Breo倍轻松’s journey. The company’s narrative is intertwined with the rise of Shenzhen’s manufacturing ecosystem and the vision of its founder.

The Vision of Ma Xuejun: From Huafa North to the STAR Market

Ma Xuejun’s career is a classic Shenzhen entrepreneurial tale. Starting from the electronics hubs of Huaqiang North (华强北), he identified a market gap in the early 2000s: the lack of portable, personal massage devices amidst a sea of bulky, expensive professional equipment. He founded the Breo倍轻松 brand in 2000, launching its first eye massager in 2001.

His strategic moves were prescient for the time. He aggressively pursued premium offline retail channels in airports and high-speed rail stations, building brand equity. Early on, he integrated smart features like Bluetooth and app control. The crowning achievement was the July 2021 IPO on the STAR Market (科创板), where shares skyrocketed over 524% on debut, cementing Breo倍轻松’s status as the “first stock” in its niche and valuing the company over 10 billion yuan.

A Crowded and Competitive Landscape

However, the market that once celebrated Breo倍轻松’s innovation has become fiercely contested. The company now faces a daunting pincer movement:
– High-End Pressure: Japanese brands with strong reputations for quality and technology dominate the premium perception that Breo倍轻松 once sought to own.
– Mid-Market Squeeze: Aggressive domestic players like SKG and Xiaomi (小米), with their ecosystem advantages and value-for-money propositions, have captured significant market share, directly challenging Breo倍轻松’s core offerings.

This intense competition has made it difficult for Breo倍轻松 to maintain pricing power and market differentiation, directly impacting its financial health.

Financial Performance: The Bleak Numbers Behind the Brand

The regulatory and legal woes are compounded by a stark deterioration in Breo倍轻松’s operational fundamentals. The company’s latest financial reports paint a picture of an enterprise under severe stress.

Quarterly Earnings Reveal a Sharp Downturn

Breo倍轻松’s Q3 2025 results were alarming. For the first nine months of the year:
– Total operating revenue was 552 million yuan, a precipitous year-on-year decline of 34.07%.
– Net profit attributable to shareholders was a loss of 65.628 million yuan, plunging 600.98% from the profit a year earlier.

The third quarter alone saw revenue of 167 million yuan, down 28.51%, with a net loss of 29.51 million yuan. Perhaps most concerning is the sequential quarterly decline: revenue dropped from 197 million yuan in Q1 to 188 million in Q2, and further to 167 million in Q3. This trend suggests weakening momentum, not a one-off shock.

Management attributed the slump primarily to a sharp contraction in online channel revenue. The net loss was blamed on shrinking sales leading to lower gross margins, coupled with inefficient sales and marketing expenditures and an inability to adjust fixed costs quickly enough in line with falling revenue.

An Unstable Recovery and Consumer Trust Issues

The current losses are particularly striking because Breo倍轻松 had only just emerged from a rough patch. In 2024, the company managed to return to profitability with a net income of 9.43 million yuan on revenue of 1.085 billion yuan. The rapid return to heavy losses in 2025 indicates its recovery was fragile and its business model remains vulnerable to market pressures.

Beyond the financials, consumer sentiment presents another challenge. On the Black Cat Complaint platform (黑猫投诉), Breo倍轻松 has accumulated 288 consumer complaints. Common grievances include product quality defects, poor after-sales service, and misleading marketing claims. This erosion of consumer trust directly impacts brand loyalty and repeat purchase rates, creating a headwind for any potential sales recovery.

The Road Ahead: Navigating Crisis and Seeking a Turnaround

The convergence of a CSRC investigation, active litigation, and operational distress creates a multifaceted crisis for Breo倍轻松. The path forward is fraught with uncertainty, but several key factors will determine the company’s fate.

Immediate Implications and Investor Considerations

The immediate priority is navigating the regulatory investigation. The outcome of the CSRC probe is paramount. Findings of serious violations could result in significant fines, reprimands for individuals, and further damage to the company’s reputation and stock price. Transparency and full cooperation are now non-negotiable. For investors, this period demands heightened caution. The traditional metrics for evaluating Breo倍轻松—growth potential, market share—are now secondary to resolving governance uncertainties and legal overhangs.

The patent lawsuit from Daido Motor, while concerning, may have a more contained financial impact if the involved products are indeed non-core, as the company states. However, it represents a distraction for management and a potential liability.

Strategic Imperatives for Long-Term Survival

For Breo倍轻松 to truly recover, it must address fundamental strategic challenges once the immediate crises are managed:
– Governance Overhaul: Rebuilding trust requires demonstrable improvements in internal controls, financial transparency, and alignment between management and all shareholders.
– Product & Innovation Revamp: The company must reassert its technological edge. This could involve doubling down on R&D for differentiated, hard-to-copy features or exploring new product categories within personal health and wellness.
– Channel Recalibration: The heavy reliance on high-cost offline retail and a struggling online presence needs reevaluation. A more efficient, omnichannel strategy tailored to today’s consumer journey is essential.
– Brand Rehabilitation: Addressing quality complaints and investing in customer service are critical to repairing the brand’s image and fostering loyalty.

Ultimately, the question of whether Breo倍轻松 can become “relaxed” again hinges on its ability to transition from a founder-driven story to a robust, professionally governed enterprise. The current crises, while severe, could serve as a catalyst for this necessary transformation if met with decisive and transparent action.

For market participants, Breo倍轻松 serves as a salient case study in the risks that can emerge in high-growth segments of China’s consumer market. It underscores the importance of scrutinizing not just top-line growth, but also the underlying quality of corporate governance and the sustainability of competitive advantages. Investors should monitor the resolution of the CSRC probe as the primary near-term catalyst, while awaiting clear signs of a viable operational turnaround strategy before considering the stock’s deep decline a value opportunity.

Eliza Wong

Eliza Wong

Eliza Wong fervently explores China’s ancient intellectual legacy as a cornerstone of global civilization, and has a fascination with China as a foundational wellspring of ideas that has shaped global civilization and the diverse Chinese communities of the diaspora.